User Name:

Password:

remember me

Forgot your password?

Not a member?

Join Now

News Topic - FDA

RSS feedDisplaying articles 1 - 10 of most recent articles

FDA debates releasing GMO mosquitoes into Florida Keys Fierce public resistance in battle against Dengue and chikungunya as many fear insects' altered DNA could enter human bloodstream
CBS News | 55 minutes ago | comment? | recommend
Let GM mosquitoes loose to bite and help cure tropical diseases - researchers British biotech firm awaiting FDA approval to release bugs in the Florida KeysChange.org petition gets more than 130,000 signatures to stop experiment Continue reading...
The Guardian | 2 hours, 49 minutes ago | comment? | recommend
Millions of GMO Insects Could Be Released in Florida Keys FDA mulls releasing genetically modified mosquitoes to fight growing threat of viral diseases
ABC News | 5 hours, 18 minutes ago | comment? | recommend
Applied Spectral Imaging Receives FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67 FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67 [PR.com]
PR.com | Jan 24, 2015 08:00 AM [GMT] | comment? | recommend
Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA DUBLIN, Jan. 23, 2015 /PRNewswire/ --Shire plc (LSE: SHP, NASDAQ: SHPG) notes the announcement today by NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) that the U.S. Food and Drug Administration (FDA) has approved NATPARA® (parathyroid hormone) as an
PR Newswire | Jan 24, 2015 01:25 AM [GMT] | comment? | recommend
FDA approves NPS drug, in move validating Shire takeover deal The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc's drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc, which recently agreed to acquire NPS for $5.2 billion. Natpara is designed to treat hypoparathyroidi
Yahoo! News | Jan 24, 2015 12:40 AM [GMT] | comment? | recommend
Novartis Bexsero vaccine approved by FDA for the prevention of meningitis B, the leading cause of bacterial meningitis in the US BASEL,Switzerland, Jan. 23, 2015 /PRNewswire/ --Novartis announced today that the US Food and Drug Administration (FDA) has granted accelerated approval of Bexsero® (Meningococcal Group B Vaccine [recombinant, adsorbed]) for active immuni
PR Newswire | Jan 23, 2015 11:35 PM [GMT] | comment? | recommend
Photo from CBS 19
FDA approves 2nd vaccine against meningitis strain Federal health regulators have approved a second vaccine to prevent a strain of bacteria that can cause deadly cases of meningitis.The Food and Drug Administration said it cleared Novartis' Bexsero vaccine against a subtype of meningococcal bacteria in pe
CBS 19 | Jan 23, 2015 10:35 PM [GMT] | comment? | recommend article from Tyler, Texas
Medtronic gets FDA approval for stomach-muscle stimulator Medtronic Inc. has received regulatory approval to sell a device for treating gastroparesis, a condition that prevents a patient's stomach from emptying normally. The Fridley-based company's Enterra II system is a pacemaker-like device. Implanted below th
bizjournals.com | Jan 23, 2015 5:30 PM [GMT] | comment? | recommend article from Minneapolis, Minnesota
FDA lifts lifetime blood ban for men who have sex with men, moves to one year deferral Wayne Glass wants to help save lives by donating blood.
Iowa State Daily | Jan 23, 2015 06:00 AM [GMT] | comment? | recommend article from Ames, Iowa